T2GO is a clinical research study that is being done to find out more about how the study drug, called dapagliflozin, works in young people aged 10–24 years who have Type 2 Diabetes. This app will help guide you as you participate in the study.
T2GO is a clinical research study that is being done to find out more about how the study drug, called dapagliflozin, works in young people aged 10–24 years who have Type 2 Diabetes. This app will help guide you as you participate in the study.